Benck, Lillian <br/><br/>
CD34+ Cell Therapy for No-Option Refractory Disabling Angina: Time for FDA Approval?  [electronic resource] 

 -  Cardiovascular revascularization medicine : including molecular interventions  03 2019 
 - 177-178 p.  digital 
<br/><br/> Publication Type: Editorial; Comment 
<br/><br/><label>ISSN: </label>1878-0938 
<br/><br/><label>Standard No.: </label>10.1016/j.carrev.2019.01.012  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angina Pectoris<br/>Cell- and Tissue-Based Therapy<br/>Humans<br/>Randomized Controlled Trials as Topic